***Full-scale policy conference taking place online***
This conference will examine priorities for tackling AMR, including progress on the UK’s five-year action plan, the impact of COVID-19 on global health systems, and the potential for harnessing new networks and opportunities for collaboration to drive forward progress.
Key areas for discussion include:
- priorities for combatting antimicrobial resistance domestically
- the outlook for international collaboration
- driving innovation and research and using shared expertise to develop new antibiotics
- improving engagement with clinicians and patients to encourage the safe use of antibiotics
- optimising the use of antimicrobials, surveillance, and infection prevention
The conference takes place following:
- the UK Government presenting to the UN its priorities for tackling ‘the silent pandemic of antimicrobial resistance’, including:
- improving the way antibiotics are used
- developing new antibiotics and supply chain safety – including via global standards
- G7 health ministers identifying antimicrobial resistance as a key area for strategic action at their recent meeting for the G7 Summit
- the UK’s five-year action plan for AMR, which outlines the priorities for achieving the UK’s 2040 vision for the containment and control of AMR
Our forums are known for attracting strong interest from policymakers and stakeholders. Places have been reserved by parliamentary pass-holders from the House of Commons and officials from DAERA, NI; Defra; the Department for International Trade; the Department of Health and Social Care; the Food Standards Agency; Food Standards Scotland; the Medicines and Healthcare products Regulatory Agency; the Office for Life Sciences; The Scottish Government; and the Welsh Government. Also due to attend are representatives from bioMerieux; Camberley Alzheimer Cafe; Dunbia; Helperby Therapeutics; Kirklees Council; LumiraDx; Marks and Spencer; Medecins Sans Frontieres/Doctors Without Borders; Medicines Discovery Catapult; Menter a Busnes; Mid Yorkshire Hospitals NHS Trust; NovaBiotics; Organic Milk Suppliers Co-operative; Pfizer; Pro-Lab Diagnostics; Robert Gordon University; Sandoz; Shionogi BV; Thermo Fisher Scientific; University of Manchester; and Werfen UK
Press passes have been reserved by representatives from the APM Health Europe; Complete Nutrition; and Politico.
Overall, we expect speakers and attendees to be a senior and informed group including Members of both Houses of Parliament, and senior government officials involved in this area of public policy, together with regulators, pharmaceutical and diagnostics companies, representatives from the NHS, executive agencies including clinical staff, pharmacists, local health systems, the independent and third sectors, patients groups, law firms, consultancies, and others affected by the issues discussed as well as academics and think tanks, and reporters from the national and specialist media.
This is a full-scale conference taking place online***
- full, four-hour programme including comfort breaks – you’ll also get a full recording and transcript to refer back to
- information-rich discussion involving key policymakers and stakeholders
- conference materials provided in advance, including speaker biographies
- speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates – we’ll provide full details)
- opportunities for live delegate questions and comments with all speakers
- a recording of the addresses, all slides cleared by speakers, and further materials are made available to all delegates afterwards as a permanent record of the proceedings
- delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
- networking too – there will be opportunities for delegates to e-meet and interact – we’ll tell you how!
Full information and guidance on how to take part will be sent to delegates before the conference